Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis-Reference-Cited by-同舟云学术

Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis

Published:2020-09-10 Issue:4 Volume:77 Page:548-559
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Benzerdjeb Nazim¹²^ORCID,Durieux Emeline¹,Tantot Juliet¹,Isaac Sylvie¹,Fontaine Juliette¹,Harou Olivier¹,Glehen Olivier²³,Kepenekian Vahan²³,Alyami Mohammad⁴,Villeneuve Laurent²⁵,Laplace Nathalie²³,Traverse‐Glehen Alexandra¹⁶,Shisheboran‐Devouassoux Mojgan¹⁷,Bakrin Naoual²³

Affiliation:

1. Laboratoire d’Anatomie et Cytologie Pathologiques Institut de Pathologie Multisite Centre de Biologie Sud Centre Hospitalier SudHospices Civils de Lyon Pierre‐BéniteFrance

2. EMR 3738 Université Lyon 1 LyonFrance

3. Département de Chirurgie Digestive et Endocrinienne Centre Hospitalier Lyon‐SudHospices Civils de Lyon Pierre‐Bénite France

4. King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia

5. Service d’Epidémiologie et de Recherche Cliniques Pôle de Santé PubliqueHospices Civils de Lyon LyonFrance

6. INSERM 1052, CNRS 5286, Lyon‐Sud Charles Mérieux Lyon‐1 Faculty Université Lyon 1 LyonFrance

7. INSERM 1052 CNRS 5286 Cancer Research Center of Lyon Equipe labellisée Ligue contre le Cancer Université Lyon 1 Lyon France

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14092

Reference29 articles.

1. Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective;Neuwirth MG;J. Gastrointest. Oncol.,2016

2. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?

3. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience

4. Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

5. Intraperitoneal-Free Cancer Cells Represent a Major Prognostic Factor in Colorectal Peritoneal Carcinomatosis

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor: A Single-Institution Experience (ID: PARROT Trial);Annals of Surgical Oncology;2023-12-15

2. What is long-term survival in patients with peritoneal metastasis from gastric, pancreatic, or colorectal cancer? A study of patients treated with systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC);Pleura and Peritoneum;2023-12-01

3. Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA;Annals of Surgical Oncology;2023-07-27

4. Peritoneal regression grading score (PRGS): first evidence for independent predictive and prognostic significance;Pleura and Peritoneum;2023-05-18

5. The role of cytology in patients undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis;Pleura and Peritoneum;2023-05-08